Targeted Nanocapsules to Save Lives

Shares

Heart attacks and heart attack like events invariably result in blood clots, almost instantaneously. If not tended to quickly, clots can prove deadly by hemorrhaging. Drugs to dissolve clots are present, but their delivery is the catch. The doctors have to deliver the right dosage, at the right time, to the right place of the clot before it’s too late.

c4cc04248d-f1_hi-res

A team of Australian scientists from the Baker IDI Heart and Diabetes Institute and the University of Melbourne have come up with a solution that could prove revolutionary in this respect, as it uses the very substance which is present in fresh clots.

Thrombin is an enzyme that plays a major role in blood clotting. It is an essential substance without which we would not be able to stop bleeding even from a minor injury. Thrombin makes cross links between clots to make them stronger.

The scientists have taken a previously approved clot buster into work, called urokinase (uPA) and loaded it into a nanocapsule. This capsule is made up of a careful design of peptide sequences arranged so that it doesn’t break down before it reaches the target.

nanocapsules

Thrombin is present is freshly formed clots. On reaching a recent clot, thrombin will break down the nanocapsule and the clot buster can work its magic. The capsule can’t break down in any other location owing to the lack of thrombin.

“If you have a clot that is old, it won’t trigger the process as there is not enough thrombin,” lead researcher Christoph Hagemeyer explains. “The intention is to give the drug as soon as possible. It could be given in a heart attack straight away, in the ambulance as soon as there are symptoms.”

[adinserter block=”7″]

Author: Technology Blog

Shares
Verified by ExactMetrics